The dry eye market has a proliferation of diagnostic and therapeutic devices that are enabling ophthalmologists to diagnose dry eye disease earlier and provide more therapeutic options.
The prevalence of dry eye disease and meibomian gland atrophy is appearing more frequently in a younger population, according to OSN Cornea/External Disease Board Member Preeya K. Gupta, MD. Gupta and colleagues published a study in Cornea reporting that 42% of pediatric patients between the ages of 4 and 17 years exhibited evidence of meibomian gland atrophy.
“This process is starting earlier, and (Read more...)
Uncategorized